查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1601280

呼吸诊断市场：按产品类型、适应症和最终用户划分 - 全球预测 2025-2030

Respiratory Diagnostics Market by Product (Assays & Reagents, Instruments & Devices, Software & Services), Test Type (Imaging Tests, Mechanical Tests, Molecular Diagnostic Tests), Indication, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年呼吸诊断市值为61.2亿美元，预计2024年将达到66.6亿美元，复合年增长率为8.67%，到2030年将达到109.6亿美元。

呼吸诊断市场包括各种旨在识别气喘、慢性阻塞性肺病和其他肺部相关疾病等呼吸系统疾病的测试、设备和技术。由于污染、吸烟和人口老化等因素，全球呼吸系统疾病的盛行率不断增加，这个市场至关重要。对准确、高效的诊断工具的需求对于改善患者预后、管理慢性病和降低医疗成本至关重要。这些诊断剂用于许多应用，例如医院、诊所、实验室和居家照护，其最终用途范围从疾病预测到治疗管理。

主要市场统计
基准年[2023] 61.2亿美元
预测年份 [2024] 66.6亿美元
预测年份 [2030] 109.6亿美元
复合年增长率（%） 8.67%

主要成长动力包括分子诊断和人工智慧整合等诊断技术的进步，提高准确性和速度。医疗保健支出的增加以及人们对呼吸系统健康意识的提高进一步推动了市场的发展。潜在的商机在于对流行病多发地区快速、准确诊断的需求推动的就地检验设备需求的不断增长。然而，先进诊断的高成本、缺乏熟练专业人员和监管障碍等挑战可能会阻碍市场成长。高度分散的市场竞争所带来的定价压力也是一个主要障碍。

业务成长的创新领域包括穿戴式呼吸监测器、远端医疗整合诊断和个人化医疗方法的开发。公司也应该利用人工智慧和巨量资料分析来增强预测分析和决策流程。诊断製造商和数位健康平台之间的合作可以透过扩大产品范围和提高消费者参与度来提供竞争优势。儘管前景光明，但必须掌握不断变化的法规并投资于培训计划以解决技能差距。市场充满活力和竞争，要求企业不断创新并适应不断变化的消费者偏好和技术进步。

市场动态：快速发展的呼吸诊断市场的关键市场洞察

供需的动态交互作用正在改变呼吸诊断市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 人口老化加剧，更容易罹患慢性呼吸道疾病
    • 呼吸系统疾病诊断试剂套件、测试和系统的核准增加
    • 人们越来越偏好远端/居家照护测试设备
  • 市场限制因素
    • 呼吸诊断面板和套件产品召回的发生以及报销政策的限制
  • 市场机会
    • 科技进步引进先进的呼吸诊断工具
    • 政府对呼吸诊断工具的措施和资助
  • 市场挑战
    • 与复杂诊断程序相关的错误风险

波特五力：驾驭呼吸诊断市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解呼吸诊断市场的外部影响

外部宏观环境因素在塑造呼吸诊断市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解呼吸诊断市场的竞争状况

对呼吸诊断市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵呼吸诊断市场供应商的绩效评估

FPNV定位矩阵是评估呼吸诊断市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人口老化加剧，更容易罹患慢性呼吸道疾病
      • 呼吸系统疾病诊断试剂套件、测试和系统的核准增加
      • 远端和居家照护测试设备越来越受欢迎
    • 抑制因素
      • 具有报销限制的呼吸诊断面板和套件产品召回案例
    • 机会
      • 科技进步引进先进的呼吸诊断工具
      • 政府对呼吸诊断工具的承诺与资助
    • 任务
      • 与复杂诊断程序相关的错误风险
  • 市场区隔分析
    • 产品：快速检测病原体的需求推动了测试和试剂的采用
    • 测试类型：提高分子诊断测试准确性和特异性的研究倡议
    • 适应症：需要先进的呼吸诊断技术来实现慢性阻塞性肺病的准确检测
    • 最终使用者：在医院和诊所采用多种诊断工具来识别和监测呼吸道疾病
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章呼吸诊断市场：副产品

  • 测定和试剂
  • 设备和装置
  • 软体和服务

第七章按测试类型分類的呼吸诊断市场

  • 影像检查
    • 电脑断层扫描
    • 磁振造影
    • 正子断层扫描
    • X射线
  • 机械测试
    • 峰值流量测试
    • 肺功能检查
    • 肺活量测定法
  • 分子诊断测试
    • DNA定序与次世代定序
    • 原位杂交
    • 微阵列
    • 核酸增幅检查
    • PCR
  • OSA 诊断测试
  • 传统诊断测试
    • 生物化学检验
    • 免疫诊断
    • 显微镜检查

第八章以适应症分類的呼吸诊断市场

  • 气喘
  • 慢性阻塞性肺病
  • 肺癌
  • 肺炎
  • 结核

第九章呼吸诊断市场：依最终用户分类

  • 诊断实验室
  • 医院/诊所
  • 调查机构

第十章北美和南美呼吸诊断市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太呼吸诊断市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲呼吸诊断市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 纽约大学 Langone Health 与飞利浦建立为期 8 年的合作伙伴关係
    • Masimo 获得新核准
    • 生物梅里埃向 FDA 提交 BIOFIRE SPOTFIRE 呼吸/威胁 (R/ST) 面板的双重 510(k) 和 CLIA 豁免申请
    • BD 获得 510(k)核准COVID-19、甲型/乙型流感和呼吸道融合病毒（RSV）联合测试
    • 瑞思迈收购睡眠和呼吸诊断软体製造商 Somnoware
    • Seagen 的 30 项诊断测试获得 IVDR 认证
    • Hologic 宣布 FDA核准Panther Fusion SARS-CoV-2/流感 A/B/RSV 检测
    • QIAGEN 在日本推出配备呼吸面板的 QIAstat-Dx，用于综合征测试
    • Thermo Fisher 与 ALPCO-GeneProof 合作扩大 CE-IVD 分子检测产品组合
    • Molbio Diagnostics 将 Truenat H3N2/H1N1 检测加入呼吸道疾病产品组合中
    • Vitalograph推出新型呼吸设备VitaloPFT系列
    • SD Biosensors 和 SJL Partners 完成 Meridian Bioscience 收购交易
    • 飞利浦和 Masimo 扩大合作伙伴关係，为世界各地的患者和医生改善远端医疗

公司名单

  • Adaltis Srl
  • Masimo Corporation
  • Merck KGaA
  • Somnoware by ResMed Corp.
  • ProAxsis by NetScientific PLC
  • Medtronic PLC
  • Hologic, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Quest Diagnostics Incorporated
  • Becton, Dickinson, and Company
  • Seegene Inc.
  • Siemens Healthineers AG
  • Abbott Laboratories
  • Vitalograph Ltd.
  • Bioneer Corporation
  • Altona Diagnostics GmbH
  • CerTest Biotec SL
  • GE HealthCare Technologies, Inc.
  • Dragerwerk AG & Co. KGaA
  • Quidel Corporation
  • Daan Gene Co., Ltd.
  • bioMerieux SA
  • SDI Diagnostics, Inc.
  • Koninklijke Philips NV
  • Bio-Rad Laboratories, Inc.
  • Sansure Biotech Inc.
  • Johnson & Johnson Services, Inc.
  • Thermo Fisher Scientific Inc.
  • ZeptoMetrix LLC
  • Diatech Pharmacogenetics srl
Product Code: MRR-894699F5EBCB

The Respiratory Diagnostics Market was valued at USD 6.12 billion in 2023, expected to reach USD 6.66 billion in 2024, and is projected to grow at a CAGR of 8.67%, to USD 10.96 billion by 2030.

The respiratory diagnostics market encompasses a wide range of tests, devices, and technologies aimed at identifying respiratory conditions such as asthma, COPD, and other lung-related illnesses. This market is pivotal due to the rising global prevalence of respiratory diseases, fueled by factors such as pollution, smoking, and aging populations. The necessity of accurate, efficient diagnostic tools is paramount to improve patient outcomes, manage chronic diseases, and reduce healthcare costs. These diagnostics are utilized in numerous applications, including hospitals, clinics, laboratories, and home care settings, with end-use scopes varying from disease prediction to therapy management.

KEY MARKET STATISTICS
Base Year [2023] USD 6.12 billion
Estimated Year [2024] USD 6.66 billion
Forecast Year [2030] USD 10.96 billion
CAGR (%) 8.67%

Key growth drivers include advancements in diagnostic technologies, such as molecular diagnostics and AI integration, which enhance accuracy and speed. Increasing healthcare expenditure, alongside greater awareness about respiratory health, further propels the market. A potential opportunity lies in the burgeoning demand for point-of-care testing devices, driven by the need for rapid and precise diagnosis in epidemic-prone regions. However, challenges like high costs of advanced diagnostics, lack of skilled professionals, and regulatory hurdles may impede market growth. Competitive pricing pressure in a highly fragmented market also presents a significant barrier.

For business growth, innovation areas include wearable respiratory monitors, telemedicine-integrated diagnostics, and development of personalized medicine approaches. Companies should also leverage AI and big data analytics for enhanced predictive analytics and decision-making processes. Collaborations between diagnostic manufacturers and digital health platforms could provide a competitive edge by expanding product reach and improving consumer engagement. Despite the promising outlook, staying abreast of evolving regulations and investing in training programs to address skill gaps are essential. The market's nature being highly dynamic and competitive necessitates companies to continuously innovate and adapt to changing consumer preferences and technological advancements.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Respiratory Diagnostics Market

The Respiratory Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing aging population with susceptibility to chronic respiratory diseases
    • Growth in the approvals for respiratory disease diagnostic kits, tests, and systems
    • Rising preferences for remote and home care testing devices
  • Market Restraints
    • Incidences of product recall of respiratory diagnosis panels and kits with limited reimbursement policies
  • Market Opportunities
    • Technological advancements to introduce sophisticated respiratory diagnostic tools
    • Government initiatives and funding for respiratory diagnostic tools
  • Market Challenges
    • Risk of errors associated with complex diagnostic procedures

Porter's Five Forces: A Strategic Tool for Navigating the Respiratory Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Respiratory Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Respiratory Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Respiratory Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Respiratory Diagnostics Market

A detailed market share analysis in the Respiratory Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Respiratory Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Respiratory Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Respiratory Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Adaltis S.r.l., Masimo Corporation, Merck KGaA, Somnoware by ResMed Corp., ProAxsis by NetScientific PLC, Medtronic PLC, Hologic, Inc., F. Hoffmann-La Roche Ltd., Quest Diagnostics Incorporated, Becton, Dickinson, and Company, Seegene Inc., Siemens Healthineers AG, Abbott Laboratories, Vitalograph Ltd., Bioneer Corporation, Altona Diagnostics GmbH, CerTest Biotec S.L., GE HealthCare Technologies, Inc., Dragerwerk AG & Co. KGaA, Quidel Corporation, Daan Gene Co., Ltd., bioMerieux S.A., SDI Diagnostics, Inc., Koninklijke Philips N.V., Bio-Rad Laboratories, Inc., Sansure Biotech Inc., Johnson & Johnson Services, Inc., Thermo Fisher Scientific Inc., ZeptoMetrix LLC, and Diatech Pharmacogenetics srl.

Market Segmentation & Coverage

This research report categorizes the Respiratory Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Assays & Reagents, Instruments & Devices, and Software & Services.
  • Based on Test Type, market is studied across Imaging Tests, Mechanical Tests, Molecular Diagnostic Tests, OSA Diagnostic Tests, and Traditional Diagnostic Tests. The Imaging Tests is further studied across Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography, and X-Ray. The Mechanical Tests is further studied across Peak Flow Test, Pulmonary Function Tests, and Spirometry. The Molecular Diagnostic Tests is further studied across DNA Sequencing & Next-Generation Sequencing, In Situ Hybridization, Microarrays, Nucleic Acid Amplification Test, and PCR. The Traditional Diagnostic Tests is further studied across Biochemical Tests, Immunodiagnostics, and Microscopy.
  • Based on Indication, market is studied across Asthma, Chronic Obstructive Pulmonary Disease, Lung Cancer, Pneumonia, and Tuberculosis.
  • Based on End-User, market is studied across Diagnostic Laboratories, Hospitals & Clinics, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing aging population with susceptibility to chronic respiratory diseases
      • 5.1.1.2. Growth in the approvals for respiratory disease diagnostic kits, tests, and systems
      • 5.1.1.3. Rising preferences for remote and home care testing devices
    • 5.1.2. Restraints
      • 5.1.2.1. Incidences of product recall of respiratory diagnosis panels and kits with limited reimbursement policies
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements to introduce sophisticated respiratory diagnostic tools
      • 5.1.3.2. Government initiatives and funding for respiratory diagnostic tools
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of errors associated with complex diagnostic procedures
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Need for rapid detection of pathogens driving the adoption of assays and reagents
    • 5.2.2. Test Type: Research initiatives to advance the accuracy and specificity of molecular diagnostic tests
    • 5.2.3. Indication: Need for advanced respiratory diagnostic technologies to attain accurate testing of chronic obstructive pulmonary disease
    • 5.2.4. End-User: Adoption of a diverse range of diagnostic tools in hospitals and clinics for identifying and monitoring respiratory ailments
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Respiratory Diagnostics Market, by Product

  • 6.1. Introduction
  • 6.2. Assays & Reagents
  • 6.3. Instruments & Devices
  • 6.4. Software & Services

7. Respiratory Diagnostics Market, by Test Type

  • 7.1. Introduction
  • 7.2. Imaging Tests
    • 7.2.1. Computed Tomography
    • 7.2.2. Magnetic Resonance Imaging
    • 7.2.3. Positron Emission Tomography
    • 7.2.4. X-Ray
  • 7.3. Mechanical Tests
    • 7.3.1. Peak Flow Test
    • 7.3.2. Pulmonary Function Tests
    • 7.3.3. Spirometry
  • 7.4. Molecular Diagnostic Tests
    • 7.4.1. DNA Sequencing & Next-Generation Sequencing
    • 7.4.2. In Situ Hybridization
    • 7.4.3. Microarrays
    • 7.4.4. Nucleic Acid Amplification Test
    • 7.4.5. PCR
  • 7.5. OSA Diagnostic Tests
  • 7.6. Traditional Diagnostic Tests
    • 7.6.1. Biochemical Tests
    • 7.6.2. Immunodiagnostics
    • 7.6.3. Microscopy

8. Respiratory Diagnostics Market, by Indication

  • 8.1. Introduction
  • 8.2. Asthma
  • 8.3. Chronic Obstructive Pulmonary Disease
  • 8.4. Lung Cancer
  • 8.5. Pneumonia
  • 8.6. Tuberculosis

9. Respiratory Diagnostics Market, by End-User

  • 9.1. Introduction
  • 9.2. Diagnostic Laboratories
  • 9.3. Hospitals & Clinics
  • 9.4. Research Institutes

10. Americas Respiratory Diagnostics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Respiratory Diagnostics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Respiratory Diagnostics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. NYU Langone Health Enters 8-Year Partnership with Philips
    • 13.3.2. Masimo Gets De Novo Approval From FDA for ORi
    • 13.3.3. bioMerieux Submits Dual 510(k) and CLIA-Waiver Application to FDA for the BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel
    • 13.3.4. BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test
    • 13.3.5. ResMed Acquires Sleep and Respiratory Diagnostics Software Maker Somnoware
    • 13.3.6. Seegene Obtains IVDR Certification for 30 Diagnostic Assays
    • 13.3.7. Hologic Announces FDA Clearance of Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay
    • 13.3.8. QIAGEN Launches QIAstat-Dx in Japan with Respiratory Panel for Syndromic Testing
    • 13.3.9. Thermo Fisher partners with ALPCO-GeneProof to Broaden Their CE-IVD Molecular Assay Portfolio
    • 13.3.10. Molbio Diagnostics adds Truenat H3N2/H1N1 Test to Respiratory Disease Portfolio
    • 13.3.11. Vitalograph Launches New Respiratory VitaloPFT Series
    • 13.3.12. SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience
    • 13.3.13. Philips and Masimo Expand Partnership To Improve Telehealth For Patients And Clinicians Around The World

Companies Mentioned

  • 1. Adaltis S.r.l.
  • 2. Masimo Corporation
  • 3. Merck KGaA
  • 4. Somnoware by ResMed Corp.
  • 5. ProAxsis by NetScientific PLC
  • 6. Medtronic PLC
  • 7. Hologic, Inc.
  • 8. F. Hoffmann-La Roche Ltd.
  • 9. Quest Diagnostics Incorporated
  • 10. Becton, Dickinson, and Company
  • 11. Seegene Inc.
  • 12. Siemens Healthineers AG
  • 13. Abbott Laboratories
  • 14. Vitalograph Ltd.
  • 15. Bioneer Corporation
  • 16. Altona Diagnostics GmbH
  • 17. CerTest Biotec S.L.
  • 18. GE HealthCare Technologies, Inc.
  • 19. Dragerwerk AG & Co. KGaA
  • 20. Quidel Corporation
  • 21. Daan Gene Co., Ltd.
  • 22. bioMerieux S.A.
  • 23. SDI Diagnostics, Inc.
  • 24. Koninklijke Philips N.V.
  • 25. Bio-Rad Laboratories, Inc.
  • 26. Sansure Biotech Inc.
  • 27. Johnson & Johnson Services, Inc.
  • 28. Thermo Fisher Scientific Inc.
  • 29. ZeptoMetrix LLC
  • 30. Diatech Pharmacogenetics srl

LIST OF FIGURES

  • FIGURE 1. RESPIRATORY DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. RESPIRATORY DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. RESPIRATORY DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. RESPIRATORY DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RESPIRATORY DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. RESPIRATORY DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ASSAYS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY X-RAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PEAK FLOW TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULMONARY FUNCTION TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OSA DIAGNOSTIC TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BIOCHEMICAL TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PNEUMONIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 133. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 140. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 141. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 142. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 143. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 148. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 149. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 150. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 151. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 156. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 158. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 160. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 164. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 165. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 166. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 167. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH KOREA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH KOREA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH KOREA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SOUTH KOREA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. TAIWAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TAIWAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 180. TAIWAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 181. TAIWAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 182. TAIWAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 183. TAIWAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. TAIWAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. THAILAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. THAILAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 188. THAILAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 189. THAILAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 190. THAILAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 191. THAILAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 192. THAILAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. VIETNAM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. VIETNAM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 196. VIETNAM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 197. VIETNAM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 198. VIETNAM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 199. VIETNAM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 200. VIETNAM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. DENMARK RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. DENMARK RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 213. DENMARK RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 214. DENMARK RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 215. DENMARK RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 216. DENMARK RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 217. DENMARK RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. EGYPT RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. EGYPT RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 221. EGYPT RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 222. EGYPT RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 223. EGYPT RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 224. EGYPT RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 225. EGYPT RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. FINLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. FINLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 229. FINLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 230. FINLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 231. FINLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 232. FINLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 233. FINLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 237. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 238. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 239. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 240. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 241. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 243. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 245. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 246. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 247. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 248. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 249. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 251. ISRAEL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. ISRAEL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 253. ISRAEL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 254. ISRAEL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 255. ISRAEL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 256. ISRAEL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 257. ISRAEL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 259. ITALY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. ITALY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 261. ITALY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 262. ITALY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 263. ITALY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 264. ITALY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 265. ITALY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. NETHERLANDS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 270. NETHERLANDS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 272. NETHERLANDS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. NIGERIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. NIGERIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 277. NIGERIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 278. NIGERIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 279. NIGERIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 280. NIGERIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 281. NIGERIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 283. NORWAY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. NORWAY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 285. NORWAY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 286. NORWAY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 287. NORWAY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 288. NORWAY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 289. NORWAY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 291. POLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 292. POLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 293. POLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 294. POLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 295. POLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 296. POLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 297. POLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 299. QATAR RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 300. QATAR RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 301. QATAR RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 302. QATAR RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 303. QATAR RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 304. QATAR RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 305. QATAR RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 306. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 307. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 308. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 309. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 310. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 311. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 312. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 313. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 314. SAUDI ARABIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 316. SAUDI ARABIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 318. SAUDI ARABIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 319. SAUDI ARABIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
  • TABLE 320. SAUDI ARABIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 321. SAUDI ARABIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 322. SOUTH AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 324. SOUTH AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRIC